Olin JT - Search Results

1

Rivastigmine in the treatment of dementia associated with Parkinson's disease: effects on activities of daily living.

Olin JT, Aarsland D, Meng X. Olin JT, et al. Dement Geriatr Cogn Disord. 2010;29(6):510-5. doi: 10.1159/000305100. Epub 2010 Jun 5. Dement Geriatr Cogn Disord. 2010. PMID: 20523050 Clinical Trial.

2

Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).

Olin JT, Bhatnagar V, Reyes P, Koumaras B, Meng X, Brannan S. Olin JT, et al. Int J Geriatr Psychiatry. 2010 Apr;25(4):419-26. doi: 10.1002/gps.2355. Int J Geriatr Psychiatry. 2010. PMID: 19670390

3

Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis.

Cummings JL, Ferris SH, Farlow MR, Olin JT, Meng X. Cummings JL, et al. Among authors: olin jt. Dement Geriatr Cogn Disord. 2010;29(5):406-12. doi: 10.1159/000296073. Epub 2010 May 21. Dement Geriatr Cogn Disord. 2010. PMID: 20502014 Clinical Trial.

4

Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses.

Alva G, Grossberg GT, Schmitt FA, Meng X, Olin JT. Alva G, et al. Among authors: olin jt. Int J Geriatr Psychiatry. 2011 Apr;26(4):356-63. doi: 10.1002/gps.2534. Int J Geriatr Psychiatry. 2011. PMID: 21312297 Clinical Trial.

5

Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's disease.

Grossberg GT, Schmitt FA, Meng X, Tekin S, Olin J. Grossberg GT, et al. Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):627-33. doi: 10.1177/1533317510385808. Am J Alzheimers Dis Other Demen. 2010. PMID: 21131668 Free PMC article. Review.

6

Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.

Farlow MR, Grossberg GT, Meng X, Olin J, Somogyi M. Farlow MR, et al. Int J Geriatr Psychiatry. 2011 Dec;26(12):1236-43. doi: 10.1002/gps.2669. Epub 2010 Dec 23. Int J Geriatr Psychiatry. 2011. PMID: 22068922 Clinical Trial.

7

Dose effects associated with rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease.

Grossberg GT, Olin JT, Somogyi M, Meng X. Grossberg GT, et al. Among authors: olin jt. Int J Clin Pract. 2011 Apr;65(4):465-71. doi: 10.1111/j.1742-1241.2011.02641.x. Epub 2011 Feb 11. Int J Clin Pract. 2011. PMID: 21309961 Clinical Trial.

8

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis.

Farlow MR, Alva G, Meng X, Olin JT. Farlow MR, et al. Among authors: olin jt. Curr Med Res Opin. 2010 Feb;26(2):263-9. doi: 10.1185/03007990903434914. Curr Med Res Opin. 2010. PMID: 19929593 Clinical Trial.

9

Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease.

Cummings JL, Farlow MR, Meng X, Tekin S, Olin JT. Cummings JL, et al. Among authors: olin jt. Clin Drug Investig. 2010;30(1):41-9. doi: 10.2165/11531270-000000000-00000. Clin Drug Investig. 2010. PMID: 19995097 Clinical Trial.

10

Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.

Schmitt FA, Aarsland D, Brønnick KS, Meng X, Tekin S, Olin JT. Schmitt FA, et al. Among authors: olin jt. Am J Alzheimers Dis Other Demen. 2010 Aug;25(5):407-13. doi: 10.1177/1533317510367486. Epub 2010 Apr 14. Am J Alzheimers Dis Other Demen. 2010. PMID: 20392860 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters